Roger Michel Selected Research

3-iodo-alpha-methyltyrosine

4/2006	Diagnostic value of 123I-IMT SPECT in the follow-up of head and neck cancer.
2/2006	Combined SPECT/CT imaging using 123I-IMT in the detection of recurrent or persistent head and neck cancer.
10/2004	123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roger Michel Research Topics

Disease

5	Neoplasms (Cancer) 03/2014 - 10/2004
3	Meningioma (Meningiomas) 01/2013 - 01/2005
2	Head and Neck Neoplasms (Head and Neck Cancer) 04/2006 - 02/2006
2	Brain Neoplasms (Brain Tumor) 04/2006 - 01/2005
1	Stroke (Strokes) 09/2014
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2008
1	Neoplasm Metastasis (Metastasis) 01/2008
1	Carcinoma (Carcinomatosis) 02/2006
1	Primitive Neuroectodermal Tumors (PNET) 01/2005
1	Ependymoma 01/2005
1	Chordoma 01/2005
1	Glioma (Gliomas) 10/2004

Drug/Important Bio-Agent (IBA)

4	Tyrosine (L-Tyrosine)FDA Link 04/2006 - 10/2004
3	3-iodo-alpha-methyltyrosineIBA 04/2006 - 10/2004
2	Edotreotide (SMT 487)IBA 01/2013 - 02/2010
2	Somatostatin Receptors (Somatostatin Receptor)IBA 02/2010 - 01/2008
2	IodineIBA 04/2006 - 02/2006
1	PhosphatidylserinesIBA 09/2014
1	Annexin A5IBA 09/2014
1	Ga(III)-DOTATOCIBA 01/2013
1	SynaptophysinIBA 01/2008
1	Chromogranin AIBA 01/2008
1	Radioisotopes (Radionuclides)IBA 01/2008
1	Amino Acids FDA Link 04/2006
1	Protons (Proton)IBA 10/2004

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 03/2014 - 01/2005
1	Radiotherapy 02/2010
1	Therapeutics 04/2006